Effects of amisulpride maintenance therapy on the quality of life of schizophrenic patients

被引：0
|
作者：
Kim, N. H. [1 ]
机构：
[1] Daegu Mental Hosp, Taegu, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2011年 / 21卷
关键词：
D O I：
10.1016/S0924-977X(11)70815-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S502 / S502
页数：1
相关论文
共 50 条
  • [31] Cognitive impairment and quality of life in schizophrenic patients
    Janovic, S
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 141 - 141
  • [32] CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY IN CHRONIC SCHIZOPHRENIC PATIENTS
    SINGH, AN
    CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1973, 18 (05): : 415 - 419
  • [33] Augmentation Treatment with Amisulpride in Schizophrenic Patients Partially Responsive to Olanzapine
    Molina, J. D.
    Toledo-Romero, F.
    Lopez-Rodriguez, E.
    Amorin-Diaz, M.
    Lerma-Carrillo, I.
    Lopez-Munoz, F.
    PHARMACOPSYCHIATRY, 2011, 44 (04) : 142 - 147
  • [34] Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride
    Danion, JM
    Rein, W
    Fleurot, O
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (04): : 610 - 616
  • [35] Quality of life effects in patients treated with the Laight®-Therapy
    Kirschner, U.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 13 - 14
  • [36] Recormon therapy: Effects on quality of life of hemodialysis patients
    Ryabov, SI
    Shostka, GD
    Petrova, NN
    Vasilyeva, IA
    Vasilyev, AN
    TERAPEVTICHESKII ARKHIV, 1996, 68 (08) : 43 - 46
  • [37] Effects of Pentoxifylline on Inflammatory Factors and Quality of Life in Maintenance Hemodialysis Patients
    Rezadoost, Lachin
    Tayebi-Khosroshahi, Hamid
    Farnood, Farahnoosh
    Sarbakhsh, Parvin
    Behzad, Hossein
    Noshad, Hamid
    Gharekhani, Afshin
    PHARMACEUTICAL SCIENCES, 2024, 30 (03) : 304 - 311
  • [38] Schizophrenic patients' opinion about disease, treatment, side-effects, and quality of life
    Knudstorp, T
    Gerlach, J
    NORDIC JOURNAL OF PSYCHIATRY, 1999, 53 (02) : 113 - 113
  • [39] Impact of the treatment with amisulpride in patients with schizophrenia and schizophrenic mood disorder
    Ojeda, GM
    Valverde, JIF
    Garrote, JAB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S254 - S254
  • [40] EFFECTS OF 6 MONTHS OF CLOZAPINE TREATMENT ON THE QUALITY OF LIFE OF CHRONIC-SCHIZOPHRENIC PATIENTS
    MELTZER, HY
    BURNETT, S
    BASTANI, B
    RAMIREZ, LF
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1990, 41 (08): : 892 - 897
12345